January 19, 2023 11:21 AM EST
News Briefing

Caris gets $400M loan from Or­biMed and Braid­well; blue­bird stock sales brings in $120M

Lei Lei Wu

News Reporter

Can­cer di­ag­nos­tic com­pa­ny Caris Life Sci­ences an­nounced it is get­ting a $400 mil­lion loan from life sci­ence in­vest­ment funds Or­biMed and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sage's roller coast­er ends in $561M ac­qui­si­tion by Su­per­nus

For­mer CEO Anne Wo­j­ci­c­ki wins bid for 23andMe

Sarep­ta halts Duchenne gene ther­a­py in some pa­tients af­ter sec­ond death

Lil­ly posts en­cour­ag­ing ear­ly-stage weight loss da­ta on amylin can­di­date

KalVista says FDA de­layed de­ci­sion on HAE drug, cit­ing ‘heavy work­load’ 

Gilead, Ar­cel­lx con­tin­ue to spot­light safe­ty of mul­ti­ple myelo­ma cell ther­a­py

A service from the Financial Times